Selected research
Industry Research
Advanced Therapy Medicinal Products Industry Research Report 2026
Market perspective
The global Advanced Therapy Medicinal Products market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Advanced Therapy Medicinal Products market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Advanced Therapy Medicinal Products market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Advanced Therapy Medicinal Products market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Advanced Therapy Medicinal Products include Novartis, Vericel Corporation, UniQure, Spark Therapeutics, PHARMICELL, MEDIPOST, Kolon TissueGene, JCR Pharmaceuticals and Gilead Lifesciences, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Advanced Therapy Medicinal Products market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Advanced Therapy Medicinal Products.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Advanced Therapy Medicinal Products Market by Company
Novartis
Vericel Corporation
UniQure
Spark Therapeutics
PHARMICELL
MEDIPOST
Kolon TissueGene
JCR Pharmaceuticals
Gilead Lifesciences
Celgene Corporation
Bluebird Bio
Advanced Therapy Medicinal Products Segment by Type
Tissue Engineered Product
Cell Therapy
Gene Therapy
CAR-T Therapy
Advanced Therapy Medicinal Products Segment by Application
Hospital
Clinic
Advanced Therapy Medicinal Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Advanced Therapy Medicinal Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Advanced Therapy Medicinal Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Advanced Therapy Medicinal Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Advanced Therapy Medicinal Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tissue Engineered Product
- Cell Therapy
- Gene Therapy
- CAR-T Therapy
Applications
- Hospital
- Clinic
Companies covered
- Novartis
- Vericel Corporation
- UniQure
- Spark Therapeutics
- PHARMICELL
- MEDIPOST
- Kolon TissueGene
- JCR Pharmaceuticals
- Gilead Lifesciences
- Celgene Corporation
- Bluebird Bio
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Advanced Therapy Medicinal Products by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Tissue Engineered Product
- 2.2.3 Cell Therapy
- 2.2.4 Gene Therapy
- 2.2.5 CAR-T Therapy
- 2.3 Advanced Therapy Medicinal Products by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.4 Assumptions and Limitations
3 Advanced Therapy Medicinal Products Breakdown Data by Type
- 3.1 Global Advanced Therapy Medicinal Products Historic Market Size by Type (2021-2026)
- 3.2 Global Advanced Therapy Medicinal Products Forecasted Market Size by Type (2027-2032)
4 Advanced Therapy Medicinal Products Breakdown Data by Application
- 4.1 Global Advanced Therapy Medicinal Products Historic Market Size by Application (2021-2026)
- 4.2 Global Advanced Therapy Medicinal Products Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Advanced Therapy Medicinal Products Market Perspective (2021-2032)
- 5.2 Global Advanced Therapy Medicinal Products Growth Trends by Region
- 5.2.1 Global Advanced Therapy Medicinal Products Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Advanced Therapy Medicinal Products Historic Market Size by Region (2021-2026)
- 5.2.3 Advanced Therapy Medicinal Products Forecasted Market Size by Region (2027-2032)
- 5.3 Advanced Therapy Medicinal Products Market Dynamics
- 5.3.1 Advanced Therapy Medicinal Products Industry Trends
- 5.3.2 Advanced Therapy Medicinal Products Market Drivers
- 5.3.3 Advanced Therapy Medicinal Products Market Challenges
- 5.3.4 Advanced Therapy Medicinal Products Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Advanced Therapy Medicinal Products Players by Revenue
- 6.1.1 Global Top Advanced Therapy Medicinal Products Players by Revenue (2021-2026)
- 6.1.2 Global Advanced Therapy Medicinal Products Revenue Market Share by Players (2021-2026)
- 6.2 Global Advanced Therapy Medicinal Products Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Advanced Therapy Medicinal Products Head Office and Area Served
- 6.4 Global Advanced Therapy Medicinal Products Players, Product Type & Application
- 6.5 Global Advanced Therapy Medicinal Products Manufacturers Established Date
- 6.6 Global Advanced Therapy Medicinal Products Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Advanced Therapy Medicinal Products Market Size (2021-2032)
- 7.2 North America Advanced Therapy Medicinal Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 7.4 North America Advanced Therapy Medicinal Products Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Advanced Therapy Medicinal Products Market Size (2021-2032)
- 8.2 Europe Advanced Therapy Medicinal Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 8.4 Europe Advanced Therapy Medicinal Products Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Advanced Therapy Medicinal Products Market Size (2021-2032)
- 9.2 Asia-Pacific Advanced Therapy Medicinal Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Advanced Therapy Medicinal Products Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Advanced Therapy Medicinal Products Market Size (2021-2032)
- 10.2 South America Advanced Therapy Medicinal Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 10.4 South America Advanced Therapy Medicinal Products Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Advanced Therapy Medicinal Products Market Size (2021-2032)
- 11.2 Middle East & Africa Advanced Therapy Medicinal Products Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Advanced Therapy Medicinal Products Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Novartis
- 12.1.1 Novartis Company Information
- 12.1.2 Novartis Business Overview
- 12.1.3 Novartis Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.1.4 Novartis Advanced Therapy Medicinal Products Product Portfolio
- 12.1.5 Novartis Recent Developments
- 12.2 Vericel Corporation
- 12.2.1 Vericel Corporation Company Information
- 12.2.2 Vericel Corporation Business Overview
- 12.2.3 Vericel Corporation Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.2.4 Vericel Corporation Advanced Therapy Medicinal Products Product Portfolio
- 12.2.5 Vericel Corporation Recent Developments
- 12.3 UniQure
- 12.3.1 UniQure Company Information
- 12.3.2 UniQure Business Overview
- 12.3.3 UniQure Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.3.4 UniQure Advanced Therapy Medicinal Products Product Portfolio
- 12.3.5 UniQure Recent Developments
- 12.4 Spark Therapeutics
- 12.4.1 Spark Therapeutics Company Information
- 12.4.2 Spark Therapeutics Business Overview
- 12.4.3 Spark Therapeutics Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.4.4 Spark Therapeutics Advanced Therapy Medicinal Products Product Portfolio
- 12.4.5 Spark Therapeutics Recent Developments
- 12.5 PHARMICELL
- 12.5.1 PHARMICELL Company Information
- 12.5.2 PHARMICELL Business Overview
- 12.5.3 PHARMICELL Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.5.4 PHARMICELL Advanced Therapy Medicinal Products Product Portfolio
- 12.5.5 PHARMICELL Recent Developments
- 12.6 MEDIPOST
- 12.6.1 MEDIPOST Company Information
- 12.6.2 MEDIPOST Business Overview
- 12.6.3 MEDIPOST Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.6.4 MEDIPOST Advanced Therapy Medicinal Products Product Portfolio
- 12.6.5 MEDIPOST Recent Developments
- 12.7 Kolon TissueGene
- 12.7.1 Kolon TissueGene Company Information
- 12.7.2 Kolon TissueGene Business Overview
- 12.7.3 Kolon TissueGene Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.7.4 Kolon TissueGene Advanced Therapy Medicinal Products Product Portfolio
- 12.7.5 Kolon TissueGene Recent Developments
- 12.8 JCR Pharmaceuticals
- 12.8.1 JCR Pharmaceuticals Company Information
- 12.8.2 JCR Pharmaceuticals Business Overview
- 12.8.3 JCR Pharmaceuticals Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.8.4 JCR Pharmaceuticals Advanced Therapy Medicinal Products Product Portfolio
- 12.8.5 JCR Pharmaceuticals Recent Developments
- 12.9 Gilead Lifesciences
- 12.9.1 Gilead Lifesciences Company Information
- 12.9.2 Gilead Lifesciences Business Overview
- 12.9.3 Gilead Lifesciences Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.9.4 Gilead Lifesciences Advanced Therapy Medicinal Products Product Portfolio
- 12.9.5 Gilead Lifesciences Recent Developments
- 12.10 Celgene Corporation
- 12.10.1 Celgene Corporation Company Information
- 12.10.2 Celgene Corporation Business Overview
- 12.10.3 Celgene Corporation Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.10.4 Celgene Corporation Advanced Therapy Medicinal Products Product Portfolio
- 12.10.5 Celgene Corporation Recent Developments
- 12.11 Bluebird Bio
- 12.11.1 Bluebird Bio Company Information
- 12.11.2 Bluebird Bio Business Overview
- 12.11.3 Bluebird Bio Revenue in Advanced Therapy Medicinal Products Business (2021-2026)
- 12.11.4 Bluebird Bio Advanced Therapy Medicinal Products Product Portfolio
- 12.11.5 Bluebird Bio Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst